ES2108684T3 - Analogo de la hormona de liberacion de la hormona luteinizante (lhrh). - Google Patents

Analogo de la hormona de liberacion de la hormona luteinizante (lhrh).

Info

Publication number
ES2108684T3
ES2108684T3 ES89902885T ES89902885T ES2108684T3 ES 2108684 T3 ES2108684 T3 ES 2108684T3 ES 89902885 T ES89902885 T ES 89902885T ES 89902885 T ES89902885 T ES 89902885T ES 2108684 T3 ES2108684 T3 ES 2108684T3
Authority
ES
Spain
Prior art keywords
hormone
lhrh
analog
luteinizing
epsilon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89902885T
Other languages
English (en)
Inventor
Fortuna Haviv
Jonathan Greer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tap Pharmaceuticals Inc
Original Assignee
Tap Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tap Pharmaceuticals Inc filed Critical Tap Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2108684T3 publication Critical patent/ES2108684T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Un procedimiento para la preparación del compuesto N-Ac-D-2-Nal-D-4-Cl-Phe-D-3-Pal-Ser-N-Me-Tyr-D-Lys(N-épsilon-nicotinoil)-Leu-Lys(N-épsilon-isopropil)-Pro-D-AlaNH2 o una sal del mismo farmacéuticamente aceptable, comprendiendo dicho procedimiento acoplar secuencialmente aminoácidos o análogos de aminoácidos adecuadamente protegidos, seguido por la eliminación de los grupos protectores.
ES89902885T 1988-02-10 1989-02-09 Analogo de la hormona de liberacion de la hormona luteinizante (lhrh). Expired - Lifetime ES2108684T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15468188A 1988-02-10 1988-02-10

Publications (1)

Publication Number Publication Date
ES2108684T3 true ES2108684T3 (es) 1998-01-01

Family

ID=22552310

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89902885T Expired - Lifetime ES2108684T3 (es) 1988-02-10 1989-02-09 Analogo de la hormona de liberacion de la hormona luteinizante (lhrh).

Country Status (5)

Country Link
EP (2) EP0400065B1 (es)
DE (1) DE68928278T2 (es)
ES (1) ES2108684T3 (es)
GR (1) GR3025403T3 (es)
WO (1) WO1989007450A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
US5480969A (en) * 1992-09-15 1996-01-02 The Administrators Of The Tulane Educational Fund Antagonists of LHRH
US5656727A (en) * 1992-09-15 1997-08-12 The Administrators Of The Tulane Educational Fund Antagonists of LHRH
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
KR100459978B1 (ko) * 1996-06-21 2005-01-15 다께다 케미칼 인더스트리즈,리미티드 펩티드제조방법
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
US6455499B1 (en) 1999-02-23 2002-09-24 Indiana University Foundation Methods for treating disorders associated with LHRH activity
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
ES2306766T3 (es) 2001-03-08 2008-11-16 The Administrators Of The Tulane Educational Fund Antagonistas de somatostatina.
US7098305B2 (en) 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
JP4407322B2 (ja) 2004-03-09 2010-02-03 味の素株式会社 ペプチドの製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU497512B2 (en) * 1975-04-15 1978-12-14 Ici Australia Limited Nona and deca-peptides
NZ188987A (en) * 1977-11-30 1982-02-23 Salk Inst For Biological Studi Peptide analogues of luteinizing hormone releasing factor
IT1149971B (it) * 1979-06-11 1986-12-10 Syntex Inc Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante
US4581169A (en) * 1982-12-21 1986-04-08 Syntex (U.S.A.) Inc. Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists
US4444759A (en) * 1982-07-26 1984-04-24 The Salk Institute For Biological Studies GnRH Antagonists II
US4504414A (en) * 1983-03-28 1985-03-12 Board Of Regents, The University Of Texas System Synthetic pyridyl-alanyl decapeptides having antiovulatory activity
US4547370A (en) * 1983-11-29 1985-10-15 The Salk Institute For Biological Studies GnRH Antagonists
US4632979A (en) * 1984-06-18 1986-12-30 Tulane Educational Fund Therapeutic LHRH analogs
US4642332A (en) * 1985-04-26 1987-02-10 The Board Of Regents, The University Of Texas System Effective hormonal peptides: D-3-Pal6 -LHRH
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
CA1339679C (en) * 1988-02-10 1998-02-17 Tap Pharmaceuticals Inc. Reduced size lhrh analogs

Also Published As

Publication number Publication date
DE68928278D1 (en) 1997-10-02
EP0400065A1 (en) 1990-12-05
EP0328090A2 (en) 1989-08-16
GR3025403T3 (en) 1998-02-27
WO1989007450A1 (en) 1989-08-24
DE68928278T2 (de) 1998-03-12
EP0328090A3 (en) 1990-08-16
EP0400065B1 (en) 1997-08-27
EP0400065A4 (en) 1991-03-13

Similar Documents

Publication Publication Date Title
ES2108684T3 (es) Analogo de la hormona de liberacion de la hormona luteinizante (lhrh).
FI940807A (fi) Peptidejä, joilla on kasvuhormonia vapauttavaa aktiivisuutta
PH16791A (en) Angiotensin-ii analogues with antagonizing effects,containing an ester group in position 8
IE32559B1 (en) Pharmaceutical preparations having an adrenocorticotropic activity
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
ES527542A0 (es) Un procedimiento para preparar nuevos peptidos
PT81991B (pt) Processo para a preparacao de derivados peptidicos, analogos a pepestatina, inibidores darenina e das proteases acidas
FI884192A0 (fi) Vesiliukoisia monoestereitä käytettäväksi farmakologisesti aktiivisten yhdisteiden kantajana ja farmaseuttisten apuaineiden liukoisuutta lisäävinä aineina
ES2053454T3 (es) Composiciones farmaceuticas que contienen peptidos del grupo de la colecistoquinina-ceruleina para la terapia de estados de shock y de insuficiencias respiratorias y cardiocirculatorias.
CO4650046A1 (es) Metodo para la sintesis de analogos de la hormona paratiroidea y del peptido relacionado con la hormona paratiroidea
NO883054L (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat inneholdende somatostatinanaloger.
AU5913096A (en) An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
ES2133295T3 (es) Peptidos ciclicos y su uso.
JPS5753414A (en) Stabilized medicinal composition
PT81345B (pt) Processo para a preparacao de novos peptideos activos sobre o sistema nervoso central com accao sobre o sistema colinergico, e de composicoes farmaceuticas contendo estes compostos
ES502688A0 (es) Un procedimiento para la preparacion de nuevos peptidos.
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
EP0193910A3 (en) Synthesis of a derivative of grf and intermediate peptides
ES2058290T3 (es) Analogos de somatostatina terapeuticos.
NO881661D0 (no) Humane rhinoviruspeptider.
AR018532A1 (es) Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas
ES504996A0 (es) Un procedimiento para aislar un polipeptido purificado
DK602787D0 (da) Sproejtelanse, navnlig til hoejtryksrensere
PT94923A (pt) Processo de preparacao de analogos "pseudo" hexapeptidos, heptapeptidos, octapeptidos e nonapeptidos da lhrh e de composicoes farmaceuticas que os contem
GB1039536A (en) Manufacture of highly active isomers of hypertensin ó and of its analogues

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 400065

Country of ref document: ES